Globus Medical Inc Shs A Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh A (G2ME34) Stock Price & Analysis

G2ME34 Stock Chart & Stats

R$52.93R$0.00(0.00%)

At close: Nov 13

Day’s Range: BRL 50.83 - BRL 52.93
52-Week Range: BRL 0.01 - BRL 65.12
Previous Close: BRL 52.93
Volume: N/A
Average Volume (3M): 24
Market Cap: BRL 54.27B
Enterprise Value: BRL 50.48B
Total Cash (Recent Filing): N/A
Total Debt (Recent Filing): N/A
Price to Earnings (P/E): 19984.1
Beta: -0.07
Next Earnings: Feb 23, 2027 (Est.)
EPS Estimate: N/A
Next Dividend Ex-Date: N/A
Dividend Yield: N/A

Globus Medical Inc Shs A Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh A News

Globus Medical price target lowered to $100 from $106 at BofA

BofA lowered the firm’s price target on Globus Medical (GMED) to $100 from $106 and keeps a Buy rating on the shares following the Q3 miss. Published first on TheFly

1w agoGMED GM0N

Globus Medical price target lowered to $90 from $100 at Truist

Truist analyst Richard Newitter lowered the firm’s price target on Globus Medical (GMED) to $90 from $100 and keeps a Buy rating on the shares. Earnings per share held in

1w agoGMED GM0N

Globus Medical price target raised to $100 from $99 at Wells Fargo

Wells Fargo raised the firm’s price target on Globus Medical (GMED) to $100 from $99 and keeps an Overweight rating on the shares. The firm notes Q3 sales missed, but

1w agoGMED GM0N

Globus Medical price target lowered to $105 from $115 at Canaccord

Canaccord analyst Caitlin Cronin lowered the firm’s price target on Globus Medical (GMED) to $105 from $115 and keeps a Buy rating on the shares. The fim said they posted

1w agoGMED GM0N

Globus Medical downgraded to Market Perform from Outperform at BMO Capital

BMO Capital analyst Vik Chopra downgraded Globus Medical (GMED) to Market Perform from Outperform with a price target of $78, down from $94. The firm wants to see clearer evidence

1w agoGMED GM0N

Globus Medical sees FY26 non-GAAP EPS $4.95-$5.05, consensus $5.00

Lowers FY26 revenue guidance to $3.09B from $3.18B-$3.22B, consensus $3.2B. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks

1w agoGMED GM0N

Globus Medical increases share repurchase program by $500M

Kyle Kline, CFO, said, “Our performance reflects disciplined execution across the business, which positions us to deliver sustained earnings growth, cash generation, and enhanced shareholder returns. To further this commitment,

1w agoGMED GM0N

Globus Medical reports Q3 non-GAAP EPS $1.23, consensus $1.20

Reports Q3 revenue $763.7M, consensus $792.46M. “Third quarter revenue finished at $764M, down slightly from the prior year quarter,” commented Keith Pfeil, CEO. “U.S. Spine faced difficult prior year comparables,

1w agoGMED GM0N

Globus Medical acquires cranial neurosurgery tech firm Synaptive Medical

Globus Medical (GMED) announced that it completed the acquisition of Synaptive Medical, deepening the company’s presence in cranial neurosurgery and positioning it for further growth in this market. Synaptive Medical

1w agoGMED GM0N

Globus Medical price target lowered to $85 from $115 at RBC Capital

RBC Capital analyst Shagun Singh lowered the firm’s price target on Globus Medical (GMED) to $85 from $115 and keeps an Outperform rating on the shares as part of a

1M agoGMED GM0N

Analyst Reiterates Buy on Globus Medical, Citing Undervalued Spine Growth and New SCRIPT-Driven Upside

Bank of America Securities analyst Travis Steed maintained a Buy rating on Globus Medical today and set a price target of $106.00. Travis Steed has given his Buy rating due

2M agoGMED GM0N

Globus Medical Buy Rating Reaffirmed as Strong Execution Supports Unchanged $115 Price Target

Analyst Caitlin Roberts from Canaccord Genuity maintained a Buy rating on Globus Medical and keeping the price target at $115.00. Caitlin Roberts has given his Buy rating due to a

3M agoGMED GM0N

Globus Medical Earns Buy Rating on Reaccelerating Spine Growth, Strong Earnings Power and Robust R&D Investments

Analyst Mathew Blackman of TD Cowen maintained a Buy rating on Globus Medical, with a price target of $115.00. Mathew Blackman has given his Buy rating due to a combination

3M agoGMED GM0N

G2ME34 FAQ

What was Globus Medical Inc Shs A Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh A’s price range in the past 12 months?

Globus Medical Inc Shs A Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh A lowest stock price was R$0.01 and its highest was R$65.12 in the past 12 months.

What is Globus Medical Inc Shs A Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh A’s market cap?

Globus Medical Inc Shs A Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh A’s market cap is R$54.27B.

When is Globus Medical Inc Shs A Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh A’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Globus Medical Inc Shs A Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh A’s earnings last quarter?

Globus Medical Inc Shs A Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh A released its earnings results on Nov 05, 2026. The company reported R$0.001 earnings per share for the quarter.

Is Globus Medical Inc Shs A Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh A overvalued?

Not enough analysts have published a price target to calculate whether the price is overvalued.

Does Globus Medical Inc Shs A Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh A pay dividends?

Globus Medical Inc Shs A Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh A does not currently pay dividends.

What is Globus Medical Inc Shs A Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh A’s EPS estimate?

Globus Medical Inc Shs A Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh A’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Globus Medical Inc Shs A Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh A have?

Globus Medical Inc Shs A Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh A has 880,332,760 shares outstanding.

What happened to Globus Medical Inc Shs A Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh A’s price movement after its last earnings report?

Globus Medical Inc Shs A Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh A reported an EPS of R$0.001 in its last earnings report. Following the earnings report the stock price went down -11.159%.

Which hedge fund is a major shareholder of Globus Medical Inc Shs A Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh A?

Currently, no hedge funds are holding shares in BR:G2ME34

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Globus Medical Inc Shs A Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh A (G2ME34) Earnings & Revenues

Historic Earnings Reports

Technical Analysis

Overall Consensus

Indicator	Bullish	Neutral	Bearish
Overall Consensus	11	6	5
Technical Analysis	2	6	2
Moving Averages	9	0	3

Technical Analysis >

Similar Stocks

Stocks similar to BR:G2ME34
Company	Price & Change	Follow
BR:B1AX34Baxter International Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 1/2 Sh
BR:FMSC34Fresenius Medical Care AG ADR Unsponsored Brazilian Depositary Receipt Repr 1 ADR
BR:P2NB34Penumbra, Inc. Unsponsored Brazilian Depositary Receipt Repr 0.033333 Sh
BR:P2OD34Insulet Corp Shs Unsponsored Brazilian Depositary Receipt Repr 0.03333333 Sh
BR:S1NN34Smith & Nephew plc Unsponsored Brazilian Depositary Receipt Repr 0.2 ADR

Compare BR:G2ME34 Stocks >

Popular Stocks

Popular Stocks
Company	Price & Change	Follow
NVDANvidia
AAPLApple
MSFTMicrosoft

G2ME34 Stock Chart & Stats

Globus Medical Inc Shs A Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh A News

Globus Medical price target lowered to $100 from $106 at BofA

Globus Medical price target lowered to $90 from $100 at Truist

Globus Medical price target raised to $100 from $99 at Wells Fargo

Globus Medical price target lowered to $105 from $115 at Canaccord

Globus Medical downgraded to Market Perform from Outperform at BMO Capital

Globus Medical sees FY26 non-GAAP EPS $4.95-$5.05, consensus $5.00

Globus Medical increases share repurchase program by $500M

Globus Medical reports Q3 non-GAAP EPS $1.23, consensus $1.20

Globus Medical acquires cranial neurosurgery tech firm Synaptive Medical

Globus Medical price target lowered to $85 from $115 at RBC Capital

Analyst Reiterates Buy on Globus Medical, Citing Undervalued Spine Growth and New SCRIPT-Driven Upside

Globus Medical Buy Rating Reaffirmed as Strong Execution Supports Unchanged $115 Price Target

Globus Medical Earns Buy Rating on Reaccelerating Spine Growth, Strong Earnings Power and Robust R&D Investments

G2ME34 FAQ

Globus Medical Inc Shs A Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh A (G2ME34) Earnings & Revenues

Technical Analysis

Overall Consensus

Similar Stocks

Popular Stocks

Become an Expert with TipRanks Premium